Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. World Health Organization. Hepatitis B. World Health Organization Fact Sheet No 204 (Updated July 2014) [accessed 2015 Dec 01]. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/ .
2. Chowdhury A, Santra A, Chakravorty A, et al. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants. J Gastroenterol Hepatol. 2005;20:1712–20.
3. Lian J, Han T, Xiang HL, et al. A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2015;23:733–7.
4. Tseng KC, Tseng CW, Hsieh TY, et al. Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues. Hepatol Res. 2015 Sep 30. doi: 10.1111/hepr.12600 . (Epub ahead of print)
5. Fong TL, Tien A, Jo KJ, et al. Durability of hepatitis B e antigen seroconversion in chronic hepatitis B patients treated with entecavir or tenofovir. Dig Dis Sci. 2015;60:3465–72.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献